COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021).

Sivasubramanian BP, Joshi S, Ravikumar DB, Madhumithaa Jagannathan, Babu S, Sripathi SR, Javvaji A, Jain P, Kumar Shanmugam D, Swami Kannan BD, Tirupathi R, Dalal R

Open source

DOI: 10.3389/fonc.2024.1446482
Published: 2024
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2024.1446482,
  title = {COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021).},
  author = {Sivasubramanian BP and Joshi S and Ravikumar DB and Madhumithaa Jagannathan and Babu S and Sripathi SR and Javvaji A and Jain P and Kumar Shanmugam D and Swami Kannan BD and Tirupathi R and Dalal R},
  year = {2024},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2024.1446482},
  url = {https://doi.org/10.3389/fonc.2024.1446482}
}

RIS

TY  - JOUR
TI  - COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021).
AU  - Sivasubramanian BP
AU  - Joshi S
AU  - Ravikumar DB
AU  - Madhumithaa Jagannathan
AU  - Babu S
AU  - Sripathi SR
AU  - Javvaji A
AU  - Jain P
AU  - Kumar Shanmugam D
AU  - Swami Kannan BD
AU  - Tirupathi R
AU  - Dalal R
PY  - 2024
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2024.1446482
UR  - https://doi.org/10.3389/fonc.2024.1446482
ER  -

APA

BP, S., S, J., DB, R., Jagannathan, M., S, B., SR, S., A, J., P, J., D, K. S., BD, S. K., R, T., & R, D. (2024). COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021).. Frontiers in oncology. https://doi.org/10.3389/fonc.2024.1446482

Source records

pubmed · retrieved 2026-09-26T11:28:26.946Z